Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 8, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
Gilead Generic Hepatitis C (HCV) Medicines License Agreement Post author:GHIAA Admin Post published:August 18, 2021 Post category: Continue ReadingGilead Generic Hepatitis C (HCV) Medicines License Agreement
Gilead Generic Hepatitis C (HCV) Medicines License Agreement Post author:GHIAA Admin Post published:August 18, 2021 Post category: Continue ReadingGilead Generic Hepatitis C (HCV) Medicines License Agreement